← Back to Clinical Trials
RecruitingNCT06395922

Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionBlockbuster LMA
SponsorTanta University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment140
SexALL
Min Age18 Years
Max Age60 Years
Start Date2024-02-06
Completion2024-06-01
Interventions
Blockbuster LMABaska Mask

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aimed to compare the performance and safety profiles of two supraglottic airway devices (SADs), the Blockbuster laryngeal mask airway (LMA) and the Baska Mask (BM), in patients underwent laparoscopic cholecystectomy (LC).

Eligibility Criteria

Inclusion Criteria: * Aged 18-60 years * Both sexes. * American Society of Anesthesiologists (ASA) physical status I-II. * Scheduled for elective LC under general anesthesia. Exclusion Criteria: * Anticipated difficult airway. * Renal dysfunction. * Hiatus hernia. * Obesity. * Pregnancy. * Patients taking rate-controlling medications, steroids, opioids, or regular antacids.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE BLOCKBUSTER LMA TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology